FDA Inspection 1155307 — Frontage Laboratories, Inc.

Frontage Laboratories, Inc. — FEI 3006799640

The FDA completed an inspection of Frontage Laboratories, Inc. on October 15, 2021 in Exton, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 15, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Exton, PA (United States)